BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/...
29 Huhti 20252min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm...
28 Huhti 20253min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show ...
24 Huhti 20253min
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x
23 Huhti 20252min
Women History Minute - Mary A. B. Brazier
In this women's history minute, Dr. Alison Christy discusses the life and legacy of Mary A. B. Brazier.
22 Huhti 20253min
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a pr...
21 Huhti 20251min
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clin...
18 Huhti 20251min
Characterizing Prodrome in Migraine
Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Show referen...
17 Huhti 20251min
